MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hc9.0000000000000341

Медицинская библиотека · Hepatology communications · 2023

Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis.

Patidar Kavish R, Guarnizo Ortiz Maria, Slaven James E, Nephew Lauren D, Vilar Gomez Eduardo, Kettler Carla D, Ghabril Marwan S, Desai Archita P, Orman Eric S, Chalasani Naga, Gawrieh Samer

Письмо в редакциюКомментарийПеревод в очереди

Аннотация

BACKGROUND

Alcohol relapse occurs frequently in alcohol-associated hepatitis (AH) survivors, but data on the frequency and course of recurrent alcohol-associated hepatitis (rAH) are sparse. We investigated the incidence, risk factors, and outcomes of rAH.

METHODS

Hospitalized patients with AH from 2010 to 2020 at a large health care system were followed until death/liver transplant, last follow-up, or end of study (December 31, 2021). AH was defined by NIAAA Alcoholic Hepatitis Consortium criteria; rAH was defined a priori as a discrete AH episode >6 months from index AH hospitalization with interim >50% improvement or normalization of total bilirubin. Multivariable competing risk analysis was performed to identify factors associated with rAH. Landmark Kaplan-Meier analysis was performed to compare survival between patients who did versus those who did not develop rAH.

RESULTS

Of 1504 hospitalized patients with AH, 1317 (87.6%) survived and were analyzed. During a 3055 person-year follow-up, 116 (8.8%) developed rAH at an annual incidence rate of 3.8% (95% CI: 2.8-4.8). On multivariable competing risk analysis, marital status [sub-HR 0.54 (95% CI: 0.34, 0.92), p=0.01] and medications for alcohol use disorder [sub-HR 0.56 (95% CI: 0.34, 0.91), p=0.02] were associated with a lower risk for rAH. On landmark Kaplan-Meier analysis, the cumulative proportion surviving at 1 year (75% vs. 90%) and 3 years (50% vs. 78%) was significantly lower in patients who developed rAH compared to those who did not develop rAH (log-rank p<0.001).

CONCLUSIONS

rAH develops in ~1 in 10 AH survivors and is associated with lower long-term survival. Medications for alcohol use disorder lower the risk for rAH and, therefore, could be a key preventative strategy to improve outcomes.

Для цитирования: Patidar Kavish R, Guarnizo Ortiz Maria, Slaven James E, Nephew Lauren D, Vilar Gomez Eduardo, Kettler Carla D, Ghabril Marwan S, Desai Archita P, Orman Eric S, Chalasani Naga, Gawrieh Samer. Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis.. Hepatology communications. 2023. DOI: 10.1097/hc9.0000000000000341.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.